Devising and properly executing strong cybersecurity programs is an imperative that overlaps virtually all industries and sectors, but pharmaceutical companies face a special level of responsibility. It is essential that consumers are able to trust in their prescription drugs and related medical treatments, and that patients are able to reliably access them while also having their data privacy protected.
It is no exaggeration to say that accessing the treatments pharmaceutical companies develop and distribute can be a matter of life and death to consumers, so the need to protect the integrity and availability of those products cannot be overstated.
